Seoul, Korea, Aug 23, 2024 – (ACN Newswire) – Avantor, Inc., a number one world supplier of mission-critical services and products to prospects within the life sciences superior applied sciences industries, has secured three prestigious awards at the esteemed Korea Biopharma Excellence Awards (KBEA) 2024. The KBEA occasion, held in conjunction with the thirteenth Annual Biologics Manufacturing Korea & sixth Vaccine World East Asia 2024 on 13-14, August 2024, underscores Avantor’s distinctive achievements in downstream processing and single-use methods, in addition to its management as a biopharma provider in Korea.
Proper: James Hwang, Head – Biopharma Functions, AMEA, Avantor
Avantor obtained the next awards:
- Greatest Bioprocessing Provider Award: Downstream Processing
- Greatest Bioprocessing Provider Award: Single Use Methods
- General Biopharma Provider of the 12 months
These accolades spotlight Avantor’s dedication to excellence and innovation in bioprocessing. The “Greatest Bioprocessing Provider Award: Downstream Processing” acknowledges Avantor’s merchandise and options that improve the effectivity and effectiveness of downstream processing in biopharmaceutical manufacturing. Supporting this success is Avantor’s Korea Innovation Buyer Assist Heart (ICSC), which serves as a hub of scientific collaboration and innovation. The ICSC workforce collaborates carefully with prospects, providing companies that assist enhance yields, cut back manufacturing prices, and guarantee environment friendly manufacturing.
The “Greatest Bioprocessing Provider Award: Single Use Methods” acknowledges Avantor’s pioneering single-use options for strengthening manufacturing capabilities, streamlining operations, and enhance scalability for biopharmaceutical corporations. Notably, this marks the fourth consecutive yr that Avantor has obtained the “Greatest Bioprocessing Provider Award: Single Use Methods,” following wins in 2022, 2021, and 2020.
The “General Biopharma Provider of the 12 months” award is a testomony to Avantor’s complete impression on the biopharma trade, reflecting the corporate’s dedication to offering high-quality services and products that drive developments in biopharmaceutical analysis and manufacturing.
Jin Younger Lee, Head, Biopharma, APAC, Avantor, expressed his gratitude for the popularity, stating, “We’re extremely honoured to obtain these prestigious awards at the Korea Biopharma Excellence Awards 2024. These accolades underscore our relentless dedication to innovation and excellence in bioprocessing and reinforces our standing as a premier provider within the biopharma trade. They’re a testomony to the laborious work and dedication of our workforce in Korea, who attempt to ship options that allow our prospects to ship life-changing therapies to the sufferers who want them.”
James Hwang, Head of Biopharma Functions, AMEA, Avantor commented on the awards and mentioned, “Receiving these awards is a testomony to our relentless dedication to advancing bioprocessing capabilities. Our dedication to innovation is embodied within the work we do at the Korea Innovation Buyer Assist Heart (ICSC). Our devoted workforce of scientists and software specialists at the ICSC assist prospects with course of optimisation, troubleshooting, new product proof of ideas, and hands-on trainings to satisfy their evolving wants. These awards not solely acknowledge our achievements but additionally spotlight the significance of collaboration and customer-centricity in advancing the biopharma trade.”
Avantor’s recognition at the Korea Biopharma Excellence Awards 2024 follows its latest success at the Asia-Pacific Biopharma Excellence Awards 2024, the place the corporate received 5 awards, additional solidifying its management place within the biopharmaceutical trade.
About Avantor
Avantor® is a number one life science instruments firm and world supplier of mission-critical services and products to the life sciences and superior know-how industries. We work side-by-side with prospects at each step of the scientific journey to allow breakthroughs in drugs, healthcare, and know-how. Our portfolio is utilized in nearly each stage of an important analysis, improvement and manufacturing actions at greater than 300,000 buyer places in 180 nations. For extra data, go toavantorsciences.com and discover us on LinkedIn, X (Twitter) and Fb.
Regional Media Contact::
Swati Chhabra
Supervisor – Company Communications, AMEA
Avantor
91-9958-404-334
swati.chhabra@avantorsciences.com
World Media Contact:
Eric Van Zanten
Head – Exterior Communications
Avantor
1-610-529-6219
eric.vanzanten@avantorsciences.com
Subject: Press launch abstract
Supply: Avantor
Sectors: BioTech, Healthcare & Pharm, MedTech
http://www.acnnewswire.com
From the Asia Company Information Community
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Company Information Community.